Cargando…
Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model
BACKGROUND: Human regulatory T cells (Treg) offer an attractive adjunctive therapy to reduce current reliance on lifelong, nonspecific immunosuppression after transplantation. Here, we evaluated the ability of ex vivo expanded human Treg to prevent the rejection of islets of Langerhans in a humanize...
Autores principales: | Wu, Douglas C., Hester, Joanna, Nadig, Satish N., Zhang, Wei, Trzonkowski, Piotr, Gray, Derek, Hughes, Stephen, Johnson, Paul, Wood, Kathryn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864182/ https://www.ncbi.nlm.nih.gov/pubmed/23917725 http://dx.doi.org/10.1097/TP.0b013e31829fa271 |
Ejemplares similares
-
In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells
por: Nadig, Satish N., et al.
Publicado: (2010) -
Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo
por: Hester, J, et al.
Publicado: (2012) -
Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34(+) Stem Cells-Reconstituted NOD-scid IL2rγ(null) Mice
por: Xiao, Fang, et al.
Publicado: (2014) -
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells
por: Arroyo Hornero, Rebeca, et al.
Publicado: (2020) -
Correction: Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34(+) Stem Cells-Reconstituted NOD-scid IL2rγ(null) Mice
Publicado: (2014)